Bufatas IV 60mg Injection contains Busulfan, an alkylating agent used in chemotherapy, especially in preparation for bone marrow or stem cell transplantation.

Brand Name: Bufatas

Composition: Busulfan

Mechanism of Action:

Busulfan inhibits transcription and DNA replication by alkylating DNA, which causes DNA strands to cross-link. In the end, this results in cell death, particularly in cells that divide quickly, like cancer cells.

Uses:

·       Chronic Myeloid Leukemia

·       Bone marrow/Stem cell transplant conditioning

·       Acute Myeloid Leukemia

·       Other hematologic malignancies

Dosage and Administration:

Often administered as 0.8 mg/kg every 6 hours for 4 days in a row (for a total of 16 doses), in addition to additional medications such as fludarabine or cyclophosphamide, depending on the regimen.

Side Effects:

·       Anemia

·       Neutropenia

·       Thrombocytopenia

·       Pulmonary fibrosis

·       Hepatic toxicity

·       Seizures

·       Nausea

·       Vomiting

·       Fatigue

Safety Advise:

Lungs  

The safety of Bufatas Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Bufatas Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Bufatas Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Bufatas should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Bufatas while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Keep below 25°C (manufacturer-specific temperature may vary). Keep out of the light.

How to use this Medication?

Drink a glass of water along with this medication. Observe the medicine label's instructions. Take your medication on a regular basis. Never take your medication more frequently than is recommended. Except as directed by your physician, do not discontinue taking.

Consult your pediatrician about this medication's use in kids. Precautions are necessary even if this medication may be recommended for specific illnesses.

References:

1.   Buggia I, Locatelli F, Regazzi MB, Zecca M. Busulfan. Annals of Pharmacotherapy. 1994 Sep;28(9):1055-62.

2.   Hassan M, Ljungman P, Bolme P, Ringden O, Syruckova Z, Bekassy A, Stary J, Wallin I, Kallberg N. Busulfan bioavailability.

3.   Bishop JB, Wassom JS. Toxicological review of busulfan (Myleran). Mutation research/reviews in genetic toxicology. 1986 Jul 1;168(1):15-45.

4.   McCune JS, Holmberg LA. Busulfan in hematopoietic stem cell transplant setting. Expert opinion on drug metabolism & toxicology. 2009 Aug 1;5(8):957-69.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India